384 related articles for article (PubMed ID: 19470704)
1. Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.
Berglund ED; Li CY; Bina HA; Lynes SE; Michael MD; Shanafelt AB; Kharitonenkov A; Wasserman DH
Endocrinology; 2009 Sep; 150(9):4084-93. PubMed ID: 19470704
[TBL] [Abstract][Full Text] [Related]
2. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
3. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
4. A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.
Badman MK; Kennedy AR; Adams AC; Pissios P; Maratos-Flier E
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1197-204. PubMed ID: 19738035
[TBL] [Abstract][Full Text] [Related]
5. Sources of plasma glucose and liver glycogen in fasted ob/ob mice.
Turner SM; Linfoot PA; Neese RA; Hellerstein MK
Acta Diabetol; 2005 Dec; 42(4):187-93. PubMed ID: 16382307
[TBL] [Abstract][Full Text] [Related]
6. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.
Markan KR; Naber MC; Ameka MK; Anderegg MD; Mangelsdorf DJ; Kliewer SA; Mohammadi M; Potthoff MJ
Diabetes; 2014 Dec; 63(12):4057-63. PubMed ID: 25008183
[TBL] [Abstract][Full Text] [Related]
7. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.
Camporez JP; Asrih M; Zhang D; Kahn M; Samuel VT; Jurczak MJ; Jornayvaz FR
J Endocrinol; 2015 Sep; 226(3):207-17. PubMed ID: 26203166
[TBL] [Abstract][Full Text] [Related]
8. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
[TBL] [Abstract][Full Text] [Related]
9. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.
Omar BA; Andersen B; Hald J; Raun K; Nishimura E; Ahrén B
Diabetes; 2014 Jan; 63(1):101-10. PubMed ID: 24062250
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
[TBL] [Abstract][Full Text] [Related]
12. Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.
Albarazanji K; Jennis M; Cavanaugh CR; Lang W; Singh B; Lanter JC; Lenhard JM; Hornby PJ
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G653-G667. PubMed ID: 30920846
[TBL] [Abstract][Full Text] [Related]
13. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. I. Effects on signaling and indices of insulin action.
Krumm CS; Giesy SL; Caixeta LS; Perfield JW; Sauerwein H; Moore BL; Boisclair YR
J Dairy Sci; 2019 Dec; 102(12):11586-11596. PubMed ID: 31548053
[TBL] [Abstract][Full Text] [Related]
15. Interplay between FGF21 and insulin action in the liver regulates metabolism.
Emanuelli B; Vienberg SG; Smyth G; Cheng C; Stanford KI; Arumugam M; Michael MD; Adams AC; Kharitonenkov A; Kahn CR
J Clin Invest; 2014 Feb; 124(2):515-27. PubMed ID: 24401271
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
17. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice.
Gong Q; Hu Z; Zhang F; Cui A; Chen X; Jiang H; Gao J; Chen X; Han Y; Liang Q; Ye D; Shi L; Chin YE; Wang Y; Xiao H; Guo F; Liu Y; Zang M; Xu A; Li Y
Hepatology; 2016 Aug; 64(2):425-38. PubMed ID: 26926384
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminoimidazole-4-carboxamide ribonucleoside treatment improves glucose homeostasis in insulin-resistant diabetic (ob/ob) mice.
Song XM; Fiedler M; Galuska D; Ryder JW; Fernström M; Chibalin AV; Wallberg-Henriksson H; Zierath JR
Diabetologia; 2002 Jan; 45(1):56-65. PubMed ID: 11845224
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of FGF21 signalling might aggravate the impairment of glucose homeostasis during the high sucrose diet induced transition from prediabetes to diabetes in WNIN/GR-Ob rats.
Kondeti S; D M DY; Mn M; S M V K P; Nemani H; Kalashikam RR
Biomed Pharmacother; 2021 May; 137():111252. PubMed ID: 33524785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
